Skip to content
  • Wednesday, 18 November 2026
  • 12:15 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Tubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases
Neuroscience & Brain Research

Tubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases

Rifan Muazin Jul 7, 2026 0

Scientists at the Baylor College of Medicine have announced a landmark discovery in the field of neurobiology, identifying a novel…

Read More
Neuroscience & Brain Research

Baylor College of Medicine Researchers Identify Tubulin as a Key Protective Factor Against Alzheimer’s and Parkinson’s Disease Pathogenesis

Rifan Muazin Jun 29, 2026 0

In a landmark study that may redefine the therapeutic landscape for neurodegenerative disorders, scientists at Baylor College of Medicine have…

Read More
Neuroscience & Brain Research

Tubulin Acts as a Molecular Chaperone to Prevent Toxic Protein Aggregation in Alzheimer’s and Parkinson’s Disease Research

Rifan Muazin Jun 21, 2026 0

Scientists at the Baylor College of Medicine have announced a significant breakthrough in the understanding of neurodegenerative pathologies, identifying a…

Read More
Quantum Synchronization Breakthrough: Multiple Time Crystals Linked in Semiconductor MaterialPharma tariffs reach smaller drugmakers as industry warns of R&D pressureCU Boulder Researchers Unveil Revolutionary Material Design Based on the Mechanics of Entangled Office StaplesUnlocking the Skeletal Blueprint: Fam102a Identified as a Master Regulator of Bone Remodeling and a Promising Target for Osteoporosis Therapies
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring SystemThe oral exposure challenge in PROTACs: What drug developers need to solve earlyThe Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALSESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
YOU MAY HAVE MISSED
Neuroscience & Brain Research
The Evolutionary Blueprint: Why the Human Brain Operates on a Crossed-Wiring System
Rifan Muazin Nov 5, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Oct 28, 2026
Environmental & Analytical Chemistry
The Silence Broken: How Brain-Computer Interfaces are Restoring the Human Voice for Those Paralyzed by ALS
Abdurrohim Arsyad Oct 28, 2026
Pharmaceutical R&D
ESMO26: KEYNOTE-C93 Backs Chemo-Free Keytruda in dMMR Endometrial Cancer
Teuku Ryan Oct 28, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ